A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

This is a multicenter, randomized, double-blind, vehicle controlled phase II clinical study to evaluate the efficacy and safety of VC005 gel in adult subjects with mild to moderate atopic dermatitis

NCT Number	NCT07598383
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Atopic Dermatitis
Enrollment	120 participants
Start Date	2026-06-01
Primary Completion	2027-02-22 (estimated)
Study Completion	2027-02-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-07